Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles.
The increase in prevalence of bladder cancer, advanced health care services, technological advancements, drug innovations with regard to the treatment of this cancer for ex launch of EOquin, and government initiatives could contribute to the growth of the bladder cancer treatment drugs market. Majority of bladder cancer patients are over the age of 60. Rise in the geriatric population is anticipated to drive the market growth. Additionally, growing awareness about bladder diseases, therapies available in the market, and increasing health care expenditure are significantly contributing toward the growth of the global bladder cancer treatment drugs market. However, rise in number of patent expirations, increase in use of generic drugs, and asymptomatic nature of the disease are some major factors that could hamper the growth of the market.North America dominates the bladder cancer treatment drugs market followed by Europe. Rise in bladder cancer cases, availability of advanced health care solutions, developed health care infrastructure, and growing concern regarding the disease in these regions are key factors attributed to the significant market share. However, rapidly increasing prevalence of bladder cancer in the Asia Pacific region, in which India being the major country having large number of patients suffering from this disease, is expected to experience a high growth rate in the bladder cancer treatment drugs market over the forecast period. Further, increasing awareness about cancer diagnosis, growing demand for improved bladder cancer treatments and therapies, developing health care infrastructure, and rising health care expenditure in the region can drive the market growth.
The report details the trend, potential and market size of Bladder Cancer Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bladder Cancer Treatment Drugsmarket, defines the market attractiveness level of Bladder Cancer Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bladder Cancer Treatment Drugs industry, describes the types of Bladder Cancer Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bladder Cancer Treatment Drugs market and the development prospects and opportunities of Bladder Cancer Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bladder Cancer Treatment Drugs market in Chapter 13.
By Player:
Pfizer
Celgene Corporation
Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Novartis International
Eli Lilly
Sanofi
By Type:
Non-Muscle-Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
By End-User:
Low-Grade Tumors
High-Grade Tumors
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bladder Cancer Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bladder Cancer Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bladder Cancer Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bladder Cancer Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bladder Cancer Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.2 United States Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.4 China Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.6 India Bladder Cancer Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Bladder Cancer Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Bladder Cancer Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Bladder Cancer Treatment Drugs Consumption Forecast (2022-2028)
9 Global Bladder Cancer Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Bladder Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non-Muscle-Invasive Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Muscle-Invasive Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2 Global Bladder Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Low-Grade Tumors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global High-Grade Tumors Consumption and Growth Rate (2017-2022)
10 Global Bladder Cancer Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non-Muscle-Invasive Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Muscle-Invasive Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Low-Grade Tumors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global High-Grade Tumors Consumption Forecast and Growth Rate (2022-2028)
11 Global Bladder Cancer Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bladder Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bladder Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bladder Cancer Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bladder Cancer Treatment Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Bladder Cancer Treatment Drugs Product and Service
-
14.2 Celgene Corporation
-
14.2.1 Celgene Corporation Company Details
-
14.2.2 Celgene Corporation Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celgene Corporation Bladder Cancer Treatment Drugs Product and Service
-
14.3 Hoffmann-La Roche
-
14.3.1 Hoffmann-La Roche Company Details
-
14.3.2 Hoffmann-La Roche Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Hoffmann-La Roche Bladder Cancer Treatment Drugs Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Bladder Cancer Treatment Drugs Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Bladder Cancer Treatment Drugs Product and Service
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Details
-
14.6.2 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Product and Service
-
14.7 Novartis International
-
14.7.1 Novartis International Company Details
-
14.7.2 Novartis International Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis International Bladder Cancer Treatment Drugs Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Bladder Cancer Treatment Drugs Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Bladder Cancer Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bladder Cancer Treatment Drugs
-
Figure Bladder Cancer Treatment Drugs Picture
-
Table Global Bladder Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bladder Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bladder Cancer Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bladder Cancer Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bladder Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bladder Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Muscle-Invasive Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Muscle-Invasive Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Low-Grade Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global High-Grade Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Muscle-Invasive Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscle-Invasive Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Low-Grade Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global High-Grade Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bladder Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bladder Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bladder Cancer Treatment Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Bladder Cancer Treatment Drugs Product and Service
-
Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Bladder Cancer Treatment Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bladder Cancer Treatment Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bladder Cancer Treatment Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Bladder Cancer Treatment Drugs Product and Service
-
Table Novartis International (Foundation Year, Company Profile and etc.)
-
Table Novartis International Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Bladder Cancer Treatment Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bladder Cancer Treatment Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Bladder Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Bladder Cancer Treatment Drugs Product and Service
-
